Skip to main content

Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 30% on print and eBooks.

Novel Anticancer Agents

Strategies for Discovery and Clinical Testing

  • 1st Edition - December 13, 2005
  • Editors: Alex A. Adjei, John K. Buolamwini
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 1 2 - 0 8 8 5 6 1 - 9
  • eBook ISBN:
    9 7 8 - 0 - 0 8 - 0 5 3 7 7 5 - 7

Novel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, tran… Read more

Novel Anticancer Agents

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Novel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents.

At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.